138 related articles for article (PubMed ID: 8748613)
1. Dopamine mediated responses in 6-hydroxydopamine lesioned rats involve changes of the signal transduction.
Barone P; Popoli M; Morelli M; Cicarelli G; Campanella G; Di Chiara G
J Neural Transm Suppl; 1995; 45():83-90. PubMed ID: 8748613
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of (-)-stepholidine on protein phosphorylation of a dopamine- and cAMP-regulated phosphoprotein in denervated striatum of oxidopamine-lesioned rats.
Guo X; Liu J; Zou LL; Jin J; Wang BC; Jin GZ
Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):100-3. PubMed ID: 10374628
[TBL] [Abstract][Full Text] [Related]
3. Behavioural sensitization in 6-hydroxydopamine lesioned rats involves the dopamine signal transduction: changes in DARPP-32 phosphorylation.
Barone P; Morelli M; Popoli M; Cicarelli G; Campanella G; Di Chiara G
Neuroscience; 1994 Aug; 61(4):867-73. PubMed ID: 7838384
[TBL] [Abstract][Full Text] [Related]
4. Increased phosphorylation of DARPP-32 by D1 agonistic action of l-stepholidine in the 6-OHDA-lesioned rat striatum.
Liu J; Guo X; Wang BC; Jin GZ
Sheng Li Xue Bao; 1999 Feb; 51(1):65-72. PubMed ID: 11972178
[TBL] [Abstract][Full Text] [Related]
5. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
Wirtshafter D; Osborn CV
Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
[TBL] [Abstract][Full Text] [Related]
6. Antagonistic effects of dopaminergic signaling and ethanol on protein kinase A-mediated phosphorylation of DARPP-32 and the NR1 subunit of the NMDA receptor.
Edwards S; Simmons DL; Galindo DG; Doherty JM; Scott AM; Hughes PD; Wilcox RE
Alcohol Clin Exp Res; 2002 Feb; 26(2):173-80. PubMed ID: 11964556
[TBL] [Abstract][Full Text] [Related]
7. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
[TBL] [Abstract][Full Text] [Related]
8. Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons.
Frau L; Morelli M; Simola N
Exp Neurol; 2013 Sep; 247():663-72. PubMed ID: 23499830
[TBL] [Abstract][Full Text] [Related]
9. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW 373U86 and SNC 80: 3. Facilitation of D1 and D2 responses in unilaterally 6-hydroxydopamine-lesioned rats.
Pinna A; Di Chiara G
Behav Pharmacol; 1998 Feb; 9(1):15-21. PubMed ID: 9832944
[TBL] [Abstract][Full Text] [Related]
10. Priming of rotational behavior by a dopamine receptor agonist in Hemiparkinsonian rats: movement-dependent induction.
Simola N; Di Chiara G; Daniels WM; Schallert T; Morelli M
Neuroscience; 2009 Feb; 158(4):1625-31. PubMed ID: 19063947
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32.
Dunah AW; Sirianni AC; Fienberg AA; Bastia E; Schwarzschild MA; Standaert DG
Mol Pharmacol; 2004 Jan; 65(1):121-9. PubMed ID: 14722243
[TBL] [Abstract][Full Text] [Related]
12. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 2. Intracerebral microinjection of dopamine agonists and antagonists.
Okamura H; Murakami T; Yokoyama C; Nakamura T; Ibata Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):1031-7. PubMed ID: 9023320
[TBL] [Abstract][Full Text] [Related]
13. The mesolimbic dopaminergic response to novel palatable food consumption increases dopamine-D1 receptor-mediated signalling with complex modifications of the DARPP-32 phosphorylation pattern.
Rauggi R; Scheggi S; Cassanelli A; De Montis MG; Tagliamonte A; Gambarana C
J Neurochem; 2005 Feb; 92(4):867-77. PubMed ID: 15686489
[TBL] [Abstract][Full Text] [Related]
14. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
Van De Witte SV; Groenewegen HJ; Voorn P
Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
[TBL] [Abstract][Full Text] [Related]
15. Dopamine modulation of membrane excitability in striatal spiny neurons is altered in DARPP-32 knockout mice.
Onn SP; Fienberg AA; Grace AA
J Pharmacol Exp Ther; 2003 Sep; 306(3):870-9. PubMed ID: 12805477
[TBL] [Abstract][Full Text] [Related]
16. Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32.
Flores-Hernández J; Cepeda C; Hernández-Echeagaray E; Calvert CR; Jokel ES; Fienberg AA; Greengard P; Levine MS
J Neurophysiol; 2002 Dec; 88(6):3010-20. PubMed ID: 12466426
[TBL] [Abstract][Full Text] [Related]
17. Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression.
Carta AR; Frau L; Pinna A; Morelli M
Exp Neurol; 2010 Aug; 224(2):395-402. PubMed ID: 20452347
[TBL] [Abstract][Full Text] [Related]
18. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
Neal-Beliveau BS; Joyce JN
Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
[TBL] [Abstract][Full Text] [Related]
19. Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement.
Papadeas ST; Blake BL; Knapp DJ; Breese GR
J Neurosci; 2004 Jun; 24(26):5863-76. PubMed ID: 15229233
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions.
Mango D; Bonito-Oliva A; Ledonne A; Nisticò R; Castelli V; Giorgi M; Sancesario G; Fisone G; Berretta N; Mercuri NB
Neuropharmacology; 2014 Jan; 76 Pt A():127-36. PubMed ID: 23973317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
